A DESCRIPTION OF BLOOD SUGAR LEVELS OF DM PATIENTS WITH ORAL HYPOGLYCEMIC DRUG ADMINISTRATION AT ONE OF THE JEMBER HOSPITALS

Abstract

Background: Diabetes Mellitus (DM) is a chronic disease caused by impaired metabolism of fat, carbohydrates and proteins, characterized by high blood sugar levels that exceed normal limits. The incidence of DM will increase every year, the increasing incidence of DM can be caused by risk factors, such as obesity, physical activity and age. This study aims to determine the use of metformin and glimepiride along with a picture of blood sugar levels of diabetes mellitus patients before and after administering single metformin and glimepiride drugs at one of the hospitals in Jember. Methods: This study includes non-experimental research, namely obervasional with analytical descriptive research design with cross sectional methods. Sampel diambil menggunakan teknik total sampling yang memenuhi kriteria inklusi sebanyak 32 pasien. Penelitian ini dilakukan di ruang rekam medis di salah satu Rumah Sakit di Jember pada bulan Juni-Juli 2023. Data were taken using observation sheets and recapitulation sheets. Research Results: The use of metformin and glimepiride drugs in type 2 DM patients in one of the hospitals in Jember is metformin as much as 15.6% while glimepiride is 84.4%. The data showed the difference in the average blood sugar levels of patients before using metformin which was 233.2 mg / dl and after using metformin which was 168.4 mg / dl and the difference in the average blood sugar levels of patients before using glimepiride was 246.7 mg / dl and after using glimepiride was 181.5 mg / dl. Conclusion: The use of metformin and glimepiride alone drugs in patients with type 2 diabetes showed that almost all patients used a single glimepiride drug which was 84.4%. Single metformin and glimepiride drugs were also able to reduce blood sugar levels of patients with type 2 diabetes in one of the outpatient installations of hospitals in Jember.